Key result
Apolipoprotein D expression increased 80-fold during disease progression in double knockout mice, and its overexpression reduced ischemia/reperfusion-induced myocardial infarction.
Why the study?
Does apolipoprotein D protect against myocardial infarction in mouse models of coronary artery disease?
Does apolipoprotein D protect against myocardial infarction in mouse models of coronary artery disease?
Apolipoprotein D acts as an intrinsic cardioprotective gene that reduces myocardial infarction size, likely through its antioxidant activity.
Answers are grounded in this paper and cite their sources.
Apolipoprotein D may attenuate infarction in mouse models; leaves open its therapeutic relevance in human coronary disease.
Mice with homozygous null mutations in the HDL receptor (scavenger receptor class B, type I, or SR-BI) and apolipoprotein E (apoE) genes [SR-BI/apoE double KO (SR-BI(-/-)/apoE(-/-) or dKO) mice] spontaneously develop occlusive, atherosclerotic coronary artery disease (CAD) and die prematurely (50% mortality at 42 d of age). Using microarray mRNA expression profiling, we identified genes whose expression in the hearts of dKO mice changed substantially during disease progression [at 21 d of age (no CAD), 31 d of age (small myocardial infarctions), and 43 d of age (extensive myocardial infarctions) vs. CAD-free SR-BI(+/-)/apoE(-/-) controls]. Expression of most genes that increased >sixfold in dKO hearts at 43 d also increased after coronary artery ligation. We examined the influence and potential mechanism of action of apolipoprotein D (apoD) whose expression in dKO hearts increased 80-fold by 43 d. Analysis of ischemia/reperfusion-induced myocardial infarction in both apoD KO mice and wild-type mice with abnormally high plasma levels of apoD (adenovirus-mediated hepatic overexpression) established that apoD reduces myocardial infarction. There was a correlation of apoD's ability to protect primary cultured rat cardiomyocytes from hypoxia/reoxygenation injury with its potent ability to inhibit oxidation in a standard antioxidation assay in vitro. We conclude that dKO mice represent a useful mouse model of CAD and apoD may be part of an intrinsic cardioprotective system, possibly as a consequence of its antioxidation activity.
No takes yet. Share an insight, caveat, or question.
Tsukamoto et al. (2013) studied Atherosclerotic coronary artery disease and myocardial infarction. Apolipoprotein D (apoD) overexpression or knockout vs. Wild-type mice or CAD-free SR-BI(+/-)/apoE(-/-) controls was evaluated on Myocardial infarction and hypoxia/reoxygenation injury. Apolipoprotein D expression increased 80-fold during disease progression in double knockout mice, and its overexpression reduced ischemia/reperfusion-induced myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: